Ignite Creation Date:
2025-12-24 @ 10:46 PM
Ignite Modification Date:
2026-01-01 @ 9:06 AM
Study NCT ID:
NCT00924469
Status:
COMPLETED
Last Update Posted:
2013-04-17
First Post:
2009-06-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer
Sponsor:
Janssen Research & Development, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-11
Start Date Type:
None
Primary Completion Date:
2012-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-03
Completion Date Type:
ACTUAL
First Submit Date:
2009-06-17
First Submit QC Date:
None
Study First Post Date:
2009-06-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-03-06
Results First Submit QC Date:
None
Results First Post Date:
2013-04-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-03-06
Last Update Post Date:
2013-04-17
Last Update Post Date Type:
ESTIMATED